Nuveen Asset Management LLC grew its position in shares of Phibro Animal Health Co. (NASDAQ:PAHC - Free Report) by 21.4% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 588,001 shares of the company's stock after acquiring an additional 103,618 shares during the quarter. Nuveen Asset Management LLC owned about 1.45% of Phibro Animal Health worth $12,348,000 as of its most recent filing with the SEC.
Several other hedge funds and other institutional investors also recently modified their holdings of PAHC. Millennium Management LLC lifted its holdings in Phibro Animal Health by 233.0% in the fourth quarter. Millennium Management LLC now owns 207,749 shares of the company's stock worth $4,363,000 after purchasing an additional 145,359 shares during the period. Lazard Asset Management LLC lifted its holdings in Phibro Animal Health by 2,739.7% in the fourth quarter. Lazard Asset Management LLC now owns 1,647 shares of the company's stock worth $34,000 after purchasing an additional 1,589 shares during the period. Jacobs Levy Equity Management Inc. lifted its holdings in Phibro Animal Health by 56.7% in the fourth quarter. Jacobs Levy Equity Management Inc. now owns 301,173 shares of the company's stock worth $6,325,000 after purchasing an additional 108,918 shares during the period. Graham Capital Management L.P. acquired a new stake in Phibro Animal Health in the fourth quarter worth about $245,000. Finally, Deutsche Bank AG lifted its holdings in Phibro Animal Health by 90.8% in the fourth quarter. Deutsche Bank AG now owns 16,873 shares of the company's stock worth $354,000 after purchasing an additional 8,032 shares during the period. Institutional investors and hedge funds own 99.34% of the company's stock.
Wall Street Analysts Forecast Growth
Several equities research analysts recently weighed in on PAHC shares. Morgan Stanley upped their price objective on shares of Phibro Animal Health from $20.00 to $21.00 and gave the stock an "equal weight" rating in a report on Thursday, May 8th. Barclays upped their price objective on shares of Phibro Animal Health from $20.00 to $22.00 and gave the stock an "underweight" rating in a report on Monday, February 10th. Finally, Wall Street Zen raised shares of Phibro Animal Health from a "hold" rating to a "buy" rating in a report on Friday, May 9th. Two equities research analysts have rated the stock with a sell rating, two have given a hold rating and one has given a buy rating to the company's stock. According to data from MarketBeat, Phibro Animal Health has a consensus rating of "Hold" and an average target price of $20.00.
Read Our Latest Report on Phibro Animal Health
Phibro Animal Health Trading Up 0.7%
NASDAQ PAHC traded up $0.16 on Thursday, hitting $24.66. 287,569 shares of the company were exchanged, compared to its average volume of 200,318. The company's 50 day moving average price is $20.41 and its 200-day moving average price is $21.90. The company has a debt-to-equity ratio of 2.99, a current ratio of 3.20 and a quick ratio of 1.37. The firm has a market capitalization of $999.57 million, a P/E ratio of 51.38, a price-to-earnings-growth ratio of 0.45 and a beta of 0.62. Phibro Animal Health Co. has a twelve month low of $16.16 and a twelve month high of $26.55.
Phibro Animal Health (NASDAQ:PAHC - Get Free Report) last issued its earnings results on Wednesday, May 7th. The company reported $0.63 earnings per share for the quarter, beating analysts' consensus estimates of $0.52 by $0.11. The company had revenue of $347.80 million for the quarter, compared to the consensus estimate of $352.41 million. Phibro Animal Health had a return on equity of 25.35% and a net margin of 1.75%. Analysts predict that Phibro Animal Health Co. will post 1.95 earnings per share for the current fiscal year.
Phibro Animal Health Announces Dividend
The firm also recently announced a quarterly dividend, which will be paid on Wednesday, June 25th. Stockholders of record on Wednesday, June 4th will be issued a $0.12 dividend. The ex-dividend date of this dividend is Wednesday, June 4th. This represents a $0.48 dividend on an annualized basis and a dividend yield of 1.95%. Phibro Animal Health's dividend payout ratio is 61.54%.
About Phibro Animal Health
(
Free Report)
Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.
Recommended Stories

Before you consider Phibro Animal Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Phibro Animal Health wasn't on the list.
While Phibro Animal Health currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for June 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.